269 related articles for article (PubMed ID: 28099818)
1. Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.
El-Nakeep S; Rashad N; Oweira H; Schmidt J; Helbling D; Giryes A; Petrausch U; Mehrabi A; Decker M; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2017 Mar; 11(3):249-258. PubMed ID: 28099818
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases.
Mirnezami R; Moran BJ; Harvey K; Cecil T; Chandrakumaran K; Carr N; Mohamed F; Mirnezami AH
World J Gastroenterol; 2014 Oct; 20(38):14018-32. PubMed ID: 25320542
[TBL] [Abstract][Full Text] [Related]
4. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?
Gelli M; Huguenin JFL; de Baere T; Benhaim L; Mariani A; Boige V; Malka D; Sourouille I; Ducreux M; Elias D; Goéré D
Eur J Cancer; 2018 Sep; 100():94-103. PubMed ID: 30014885
[TBL] [Abstract][Full Text] [Related]
6. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
7. Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
Navez J; Remue C; Leonard D; Bachmann R; Kartheuser A; Hubert C; Coubeau L; Komuta M; Van den Eynde M; Zech F; Jabbour N
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):666-673. PubMed ID: 27646023
[TBL] [Abstract][Full Text] [Related]
8. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment?
Pinto A; Hobeika C; Philis A; Kirzin S; Carrère N; Ghouti L
Langenbecks Arch Surg; 2019 Jun; 404(4):477-488. PubMed ID: 31025165
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection for concurrent peritoneal and hepatic metastases of gastrointestinal and gynecological primary tumors.
Horvath P; Beckert S; Königsrainer A; Nadalin S; Königsrainer I
J Visc Surg; 2019 Dec; 156(6):475-484. PubMed ID: 31324533
[TBL] [Abstract][Full Text] [Related]
10. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery (CR) followed by hyperthermic intraperitoneal chemotherapy (HIPEC): a chance of survival for patients with advanced colorectal cancer.
Bartoş A; Bartoş DM; Breazu C; Hosu M; Stoian R; Iancu C
J Gastrointestin Liver Dis; 2015 Sep; 24(3):392-3. PubMed ID: 26405715
[No Abstract] [Full Text] [Related]
12. Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review.
van Oudheusden TR; Nienhuijs SW; Luyer MD; Nieuwenhuijzen GA; Lemmens VE; Rutten HJ; de Hingh IH
Eur J Surg Oncol; 2015 Oct; 41(10):1269-77. PubMed ID: 26175345
[TBL] [Abstract][Full Text] [Related]
13. The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
Waite K; Youssef H
Ann Surg Oncol; 2017 Mar; 24(3):705-720. PubMed ID: 28058545
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.
Trilling B; Cotte E; Vaudoyer D; Isaac S; Piaton E; Maurice C; Glehen O; Passot G
Dis Colon Rectum; 2016 Jul; 59(7):615-22. PubMed ID: 27270513
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.
Seshadri RA; Glehen O
World J Gastroenterol; 2016 Jan; 22(3):1114-30. PubMed ID: 26811651
[TBL] [Abstract][Full Text] [Related]
16. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
Chua TC; Yan TD; Zhao J; Morris DL
Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?
Delhorme JB; Dupont-Kazma L; Addeo P; Lefebvre F; Triki E; Romain B; Meyer N; Bachellier P; Rohr S; Brigand C
Int J Surg; 2016 Jan; 25():98-105. PubMed ID: 26607853
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis.
Ceelen W; Van Nieuwenhove Y; Putte DV; Pattyn P
Ann Surg Oncol; 2014 Sep; 21(9):3023-8. PubMed ID: 24756812
[TBL] [Abstract][Full Text] [Related]
20. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.
Passot G; Vaudoyer D; Cotte E; You B; Isaac S; Noël Gilly F; Mohamed F; Glehen O
Ann Surg; 2012 Jul; 256(1):125-9. PubMed ID: 22580942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]